作为识别急性冠状动脉综合征高风险患者的生物标志物,囊素C:一项观察性研究
Xinlin Xiong1, Li Yuan1, Xiaobin Long1
1Department of cardiology, Clinical Medical College& Affiliated Hospital of Chengdu University, Chengdu city, PR China.
概括
升高的囊C水平与患有急性冠状动脉综合征 (ACS) 的高风险患者有关. 这种生物标志物在识别和预测高风险ACS患者方面表现有前途,有助于临床风险分层.
科学领域:
- 心血管医学 心血管医学
- 生物标志物发现发现
- 临床化学 临床化学
背景情况:
- 在体液中发现的囊蛋白酶抑制剂Cystatin C与动脉样硬化心血管疾病有关.
- 在高风险急性冠状动脉综合征 (ACS) 患者中,囊素C的作用需要进一步研究.
研究的目的:
- 调查囊素C与高风险ACS患者之间的关联.
- 确定囊素C是否改善了ACS中的风险分层.
主要方法:
- 招募了219名ACS患者.
- 测量了囊素C水平,并计算了全球急性冠状动脉事件注册表 (GRACE) 的得分.
- 使用GRACE分数和基利普分类来确定高风险患者.
主要成果:
- 在所有ACS亚型中,与非高风险患者相比,高风险ACS患者的cystatin C水平显著更高.
- 受体运行特征 (ROC) 曲线分析表明,在识别高风险患者时,囊素C的区分性表现很好.
- 多变量逻辑回归证实高酸C作为高风险ACS的独立预测因子.
结论:
- 在高风险的ACS患者和亚组中,囊素C显著升高.
- 酸C作为一个有价值的生物标志物,用于区分和预测高风险的ACS.
- 赛斯塔丁C对ACS患者临床风险分层具有重要意义.
更多相关视频
04:40Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
15.1K
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
8.2K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
69
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
69
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38